Chris Cameron
Overview
Explore the profile of Chris Cameron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
4311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Igarashi A, Tanaka S, De Moor R, Li N, Hirozane M, Wu D, et al.
Adv Ther
. 2025 Jan;
42(1):70-71.
PMID: 39760977
No abstract available.
2.
Igarashi A, Tanaka S, De Moor R, Li N, Hirozane M, Wu D, et al.
Adv Ther
. 2024 Nov;
42(1):52-69.
PMID: 39531127
Introduction: Indirect treatment comparisons (ITCs) evaluate novel treatments compared to appropriate comparators when direct evidence is unavailable or infeasible. The objective of this study was to highlight the prevalence of...
3.
Tanaka S, Igarashi A, De Moor R, Li N, Hirozane M, Hong L, et al.
Value Health
. 2024 Jun;
27(9):1179-1190.
PMID: 38843980
Objectives: Controls and governance over the methodology and reporting of indirect treatment comparisons (ITCs) have been introduced to minimize bias and ensure scientific credibility and transparency in healthcare decision making....
4.
5.
Buckstein R, Chodirker L, Yee K, Geddes M, Leitch H, Christou G, et al.
Leuk Lymphoma
. 2023 Jan;
64(3):651-661.
PMID: 36606533
Many patients with lower-risk myelodysplastic syndromes (LR MDS) require long-term red blood cell (RBC) transfusions to manage anemia. The consequences of RBC transfusions in LR MDS with ring sideroblasts (LR...
6.
Cheung W, Cameron C, Mitha A, Wills A
Support Care Cancer
. 2022 Dec;
31(1):5.
PMID: 36512133
Background: Outcomes-based agreements (OBAs) have the potential to provide more timely patient access to novel therapies, although they are not suitable for every new medication or reimbursement scenario. The authors...
7.
Buckstein R, Chodirker L, Mozessohn L, Yee K, Geddes M, Zhu N, et al.
Leuk Lymphoma
. 2022 Sep;
63(13):3165-3174.
PMID: 36095125
Patients with lower-risk (LR) myelodysplastic syndromes (MDS) with ring sideroblasts (RS) have better prognosis than those without RS, but how they fare over time is not fully understood. This study's...
8.
Samjoo I, Klotz L, Giovannoni G, Drudge C, Haltner A, Worthington E, et al.
Mult Scler Relat Disord
. 2022 Jul;
66:104031.
PMID: 35841716
Background: Ofatumumab is a subcutaneously administered anti-CD20 monoclonal antibody (MoAb) therapy that has been evaluated in two identically designed randomized controlled trials (RCTs), ASCLEPIOS I (NCT02792218) and ASCLEPIOS II (NCT02792231),...
9.
Cree B, Greenberg B, Cameron C, Weinshenker B
Neurol Ther
. 2022 Jul;
11(3):1439-1443.
PMID: 35779190
No abstract available.
10.
Smith R, Rolfe A, Cameron C, Shaw G, Chase J, Pretty C
HardwareX
. 2022 May;
11:e00318.
PMID: 35637841
Acquiring patient physiological waveforms is useful for studying hemodynamic management and developing medical monitoring systems. A low cost, Arduino controlled data acquisition system acquires arterial pressure waveforms (Edwards Lifesciences TruWave...